Proanthocyanidins

Proanthocyanidins at a Glance

Proanthocyanidins are a class, not a compound. They are the condensed tannins: chains of flavan-3-ol units — catechin, epicatechin and their gallocatechin relatives — joined into oligomers and polymers, and they are what makes bark, seed and unripe fruit taste astringent. The name comes from a laboratory reaction: heat them in acid and the chains break to release coloured anthocyanidins, cyanidin from the catechin-derived procyanidins and delphinidin from the gallocatechin-derived prodelphinidins.

Two structural facts carry almost all the practical weight, and both are about how the units are joined rather than what they are.

The first is the A-type linkage. Most proanthocyanidins are B-type, joined by a single carbon-carbon bond. Cranberry’s carry an extra ether bridge, and that difference appears to be what makes them work: isolated A-type cranberry proanthocyanidins blocked E. coli adhesion at 60 µg/mL, while B-type proanthocyanidins from grape managed only minor activity at twenty times the concentration and those from apple, green tea and dark chocolate did nothing at all ^{1Reference 1Howell AB et al. · 2005Clinical trialA-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity — in vitro and clinical trialView study →}.

The second is chain length. Monomers and small oligomers are absorbed to a limited extent; larger polymers essentially are not, and pass to the colon. In a controlled human trial, monomeric flavanols were converted to absorbable microbial metabolites about tenfold more efficiently than oligomeric procyanidins delivering an equivalent dose ^{6Reference 6Hollands WJ et al. · 2020RCTMonomeric flavanols are more efficient substrates for gut microbiota conversion to hydroxyphenyl-γ-valerolactone metabolites than oligomeric procyanidins: a randomized, placebo-controlled human intervention trial — randomised controlled trialView study →}. That single fact explains why proanthocyanidin research so often reports effects in the gut and the urinary tract rather than in the tissues an antioxidant story would predict.

A-Type and B-Type

The interflavan bond is the class’s most consequential variable.

B-type proanthocyanidins — the ordinary kind, and the great majority — are joined by a single carbon-carbon bond between the units, C4 to C8 or C4 to C6. Grape seed, cocoa, apple, tea and most fruit proanthocyanidins are B-type, and the familiar dimers procyanidin B1 and procyanidin B2 are their reference structures.

A-type proanthocyanidins carry an additional ether bond, C2 to O7, locking the two units into a rigid doubly-linked arrangement. They are much less common, and cranberry is the notable source.

The comparison that establishes why this matters was done directly. A-type proanthocyanidins isolated from cranberry juice cocktail, B-type from commercial grape and apple juice, green tea and dark chocolate, all structurally confirmed by mass spectrometry, were tested for their ability to prevent P-fimbriated uropathogenic E. coli adhering to uroepithelial cells. The A-type cranberry fraction was active at 60 µg/mL; the grape B-type showed only minor activity at 1,200 µg/mL; the rest were inactive. Anti-adhesion activity was then detectable in human urine after drinking cranberry juice cocktail, and not after any of the other products ^{1Reference 1Howell AB et al. · 2005Clinical trialA-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity — in vitro and clinical trialView study →}.

That is as clean a structure-activity result as this class offers, and it is the reason cranberry cannot be substituted with another proanthocyanidin source.

What the Human Trials Do and Do Not Show

Proanthocyanidins have more human data than most plant polyphenols, and it is worth being precise about what the trials tested.

Urinary tract infection — the strongest evidence, and population-dependent. The Cochrane review of cranberry products for preventing urinary tract infection now covers 50 studies and 8,857 participants. Cranberry products reduced the risk of symptomatic, culture-verified infection overall (relative risk 0.70, 95% CI 0.58–0.84, moderate certainty), and the benefit held in three specific groups: women with recurrent infections (RR 0.74), children (RR 0.46) and people made susceptible by an intervention (RR 0.47). It did not hold in elderly institutionalised people (RR 0.93), pregnant women (RR 1.06) or adults with neuromuscular bladder dysfunction (RR 0.97) ^{2Reference 2Williams G et al. · 2023Systematic reviewCranberries for preventing urinary tract infections — systematic reviewView study →}. Dose matters and has been measured: anti-adhesion activity in urine following cranberry powder standardised for proanthocyanidin content was dose-dependent in a multicentre randomised trial ^{3Reference 3Howell AB et al. · 2010RCTDosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study — randomised controlled trialView study →}.

Vascular — real but small, and from one preparation. In a randomised, double-blind, placebo-controlled trial in 30 middle-aged Japanese adults with prehypertension, 400 mg/day of grape seed proanthocyanidin extract lowered mean systolic pressure by 13 mmHg over 12 weeks (P = 0.028), while flow-mediated dilation did not change; a 200 mg/day arm did not reach significance, and measures of arterial stiffness improved in a post-hoc analysis restricted to non-smokers ^{5Reference 5Odai T et al. · 2019RCTEffects of grape seed proanthocyanidin extract on vascular endothelial function in participants with prehypertension: a randomized, double-blind, placebo-controlled study — randomised controlled trialView study →}. The grape-seed preparation with the longest research history, developed from Masquelier’s 1947 work, has an 8-week supplementation study reporting favourable vascular changes in healthy volunteers ^{4Reference 4Weseler AR · 2017ReviewMasquelier’s grape seed extract: from basic flavonoid research to a well-characterized food supplement with health benefits — reviewView study →}.

Cancer — preclinical. Grape seed proanthocyanidins are widely described as chemopreventive on the strength of cell and animal work: suppression of tumour-induced angiogenesis through VEGF and Ang1 in colon cancer models ^{8Reference 8Huang S et al. · 2012In vitroGrape seed proanthocyanidins inhibit colon cancer-induced angiogenesis through suppressing the expression of VEGF and Ang1 — in vitroView study →}, and a large free-radical-scavenging and cancer-prevention literature ^{9Reference 9Bagchi D et al. · 2014ReviewFree radical scavenging, antioxidant and cancer chemoprevention by grape seed proanthocyanidin: an overview — reviewView study →}. There is no human cancer outcome.

What none of it shows is an effect of “proanthocyanidins” as such. Every positive human result belongs to a specific standardised preparation — a cranberry product with a stated proanthocyanidin content, a particular grape seed extract at a particular dose — and the class name is a description of what those products contain, not a claim that any proanthocyanidin-bearing plant does the same thing.

What It's Used For

The evidence sorts by where the compounds get to. Effects in the gut lumen and the urinary tract are the best supported; systemic antioxidant claims run into the absorption problem.

Evidence by IndicationStrength of support · Beta

01Urinary Tract Infection (A-Type)Promising66%Cochrane review of 50 trials plus a direct structure-activity comparison and a dose-ranging urine study ^{1,2,3Reference 1Howell AB et al. · 2005Clinical trialA-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity — in vitro and clinical trialView study →Reference 2Williams G et al. · 2023Systematic reviewCranberries for preventing urinary tract infections — systematic reviewView study →Reference 3Howell AB et al. · 2010RCTDosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study — randomised controlled trialView study →}

02Astringency & Traditional Tannin UsePromising46%Pharmacopoeial tannin minimums, bark extract chemistry, and centuries of tanning use ^{11,12Reference 11Pietarinen SP et al. · 2006Knotwood and bark extracts: strong antioxidants from waste materialsView study →Reference 12European Medicines Agency · 2015ReviewAssessment report on Vaccinium myrtillus L., fructus recens and fructus siccus — monograph}

03Vascular & Blood PressureShaky40%One 30-participant randomised trial of a standardised grape seed extract ^{4,5Reference 4Weseler AR · 2017ReviewMasquelier’s grape seed extract: from basic flavonoid research to a well-characterized food supplement with health benefits — reviewView study →Reference 5Odai T et al. · 2019RCTEffects of grape seed proanthocyanidin extract on vascular endothelial function in participants with prehypertension: a randomized, double-blind, placebo-controlled study — randomised controlled trialView study →}

04Antioxidant & AnticancerShaky26%Extensive cell and animal work, undercut by poor absorption; no human outcome ^{6,8,9Reference 6Hollands WJ et al. · 2020RCTMonomeric flavanols are more efficient substrates for gut microbiota conversion to hydroxyphenyl-γ-valerolactone metabolites than oligomeric procyanidins: a randomized, placebo-controlled human intervention trial — randomised controlled trialView study →Reference 8Huang S et al. · 2012In vitroGrape seed proanthocyanidins inhibit colon cancer-induced angiogenesis through suppressing the expression of VEGF and Ang1 — in vitroView study →Reference 9Bagchi D et al. · 2014ReviewFree radical scavenging, antioxidant and cancer chemoprevention by grape seed proanthocyanidin: an overview — reviewView study →}

Mechanisms

The pattern across the table is that proanthocyanidins act where they are concentrated — on surfaces, in the gut lumen and in the urinary tract — rather than systemically.

Pharmacokinetics

Absorption is the defining constraint, and it depends on chain length. Monomeric flavanols are absorbed to a modest degree and extensively metabolised; oligomers and polymers are largely not absorbed and pass into the colon, where the microbiota degrade some of them to smaller phenolic acids and hydroxyphenyl-γ-valerolactones. The comparison has been made directly in people: over 28 days, an apple extract delivering monomeric flavanols produced tenfold higher urinary excretion of these metabolites than one delivering an equivalent dose as oligomeric procyanidins, with roughly 22% of catechins converted against limited conversion of the oligomers ^{6Reference 6Hollands WJ et al. · 2020RCTMonomeric flavanols are more efficient substrates for gut microbiota conversion to hydroxyphenyl-γ-valerolactone metabolites than oligomeric procyanidins: a randomized, placebo-controlled human intervention trial — randomised controlled trialView study →}.

Two consequences follow, and they point in opposite directions. Systemic claims for the oligomeric fraction are poorly supported, because very little of it reaches the circulation. But poor absorption is itself a mechanism where the target is luminal — the unabsorbed polymers arrive in the colon at high concentration, which is a plausible reason the preclinical anticancer signal is strongest for the colon ^{8Reference 8Huang S et al. · 2012In vitroGrape seed proanthocyanidins inhibit colon cancer-induced angiogenesis through suppressing the expression of VEGF and Ang1 — in vitroView study →}, and the anti-adhesion story works because the active material is excreted into urine rather than retained ^{1,3Reference 1Howell AB et al. · 2005Clinical trialA-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity — in vitro and clinical trialView study →Reference 3Howell AB et al. · 2010RCTDosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study — randomised controlled trialView study →}.

Clinical Trials

Human trials exist in quantity but always test products, not the class: cranberry preparations for urinary tract infection, 50 trials pooled in Cochrane ^{2,3Reference 2Williams G et al. · 2023Systematic reviewCranberries for preventing urinary tract infections — systematic reviewView study →Reference 3Howell AB et al. · 2010RCTDosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study — randomised controlled trialView study →}, and standardised grape seed extract for vascular endpoints ^{4,5Reference 4Weseler AR · 2017ReviewMasquelier’s grape seed extract: from basic flavonoid research to a well-characterized food supplement with health benefits — reviewView study →Reference 5Odai T et al. · 2019RCTEffects of grape seed proanthocyanidin extract on vascular endothelial function in participants with prehypertension: a randomized, double-blind, placebo-controlled study — randomised controlled trialView study →}. The bioavailability trial ^{6Reference 6Hollands WJ et al. · 2020RCTMonomeric flavanols are more efficient substrates for gut microbiota conversion to hydroxyphenyl-γ-valerolactone metabolites than oligomeric procyanidins: a randomized, placebo-controlled human intervention trial — randomised controlled trialView study →} is the other well-designed human study, and it is a negative one for the systemic hypothesis.

Last checked: September 2026.

Isolate vs. Plant Studies

This class cannot really be isolated in the ordinary sense, because there is no single molecule to purify. What exists instead is a spectrum of preparations, and the position on that spectrum decides how much a result can be trusted:

• Structurally defined fractions — the A-type and B-type proanthocyanidins compared by mass spectrometry in the anti-adhesion study ^{1Reference 1Howell AB et al. · 2005Clinical trialA-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity — in vitro and clinical trialView study →} — support real structure-activity conclusions.
• Standardised extracts — grape seed extract at a defined proanthocyanidin content, cranberry powder standardised for proanthocyanidins — support product-level conclusions, and the trials above are all of this kind ^{3,4,5Reference 3Howell AB et al. · 2010RCTDosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study — randomised controlled trialView study →Reference 4Weseler AR · 2017ReviewMasquelier’s grape seed extract: from basic flavonoid research to a well-characterized food supplement with health benefits — reviewView study →Reference 5Odai T et al. · 2019RCTEffects of grape seed proanthocyanidin extract on vascular endothelial function in participants with prehypertension: a randomized, double-blind, placebo-controlled study — randomised controlled trialView study →}.
• Whole plant material — bark, dried fruit, seed — supports very little quantitatively, because chain-length distribution and content vary with species, part, season and processing.

The standardisation problem is not incidental. Commercial extracts differ substantially in oligomer size and proanthocyanidin content between manufacturers, which changes both absorption and effect ^{4Reference 4Weseler AR · 2017ReviewMasquelier’s grape seed extract: from basic flavonoid research to a well-characterized food supplement with health benefits — reviewView study →}, and different brands of the same nominal supplement have produced measurably different results in the same assay ^{7Reference 7Wanwimolruk S et al. · 2009In vitroVariable inhibitory effect of different brands of commercial herbal supplements on human cytochrome P-450 CYP3A4 — in vitroView study →}. A milligram figure from one product is not a dose of another.

Its Role in Plants

Condensed tannins are defence chemistry, and their distribution follows the job. They accumulate in bark, seed coats and unripe fruit — the tissues a plant most needs to protect from herbivores, insects and fungal attack — and their protein-binding astringency is the deterrent, making tissue unpalatable and reducing the digestibility of what is eaten anyway. The same chemistry preserves dead tissue, which is why tannin-rich bark resists decay and why tanning works on leather at all.

The ripening of fruit is the clearest demonstration. Unripe fruit is astringent and well defended; as it ripens and the seed becomes viable, proanthocyanidins are polymerised or bound and the astringency falls away, which is precisely when the plant wants the fruit eaten. Seeds keep theirs — grape seed remains astringent in a ripe grape.

Prevalence in Nature

Proanthocyanidins are among the most widely distributed plant polyphenols, concentrated wherever a plant invests in defence.

Barks are the richest sources. Western hemlock (Tsuga heterophylla) bark carries enough condensed tannin to have been used industrially, and its bark and knotwood extracts are studied as antioxidants recovered from wood-processing waste ^{11Reference 11Pietarinen SP et al. · 2006Knotwood and bark extracts: strong antioxidants from waste materialsView study →}; pine bark is the source of the standardised extracts sold for the oligomeric fraction; and witch hazel bark’s polymeric proanthocyanidins carry its astringency. Seeds are next: grape seed is the defining source of the oligomeric proanthocyanidin trade, standardised to a stated proanthocyanidin content ^{4Reference 4Weseler AR · 2017ReviewMasquelier’s grape seed extract: from basic flavonoid research to a well-characterized food supplement with health benefits — reviewView study →}.

Among fruits, cranberry is unique for its A-type structures ^{1Reference 1Howell AB et al. · 2005Clinical trialA-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity — in vitro and clinical trialView study →}; bilberry dried fruit carries a pharmacopoeial minimum of 1.0% tannins, distinct from its anthocyanins ^{12Reference 12European Medicines Agency · 2015ReviewAssessment report on Vaccinium myrtillus L., fructus recens and fructus siccus — monograph}; and cocoa, apple, hawthorn, chokecherry and most rose-family fruits carry B-type procyanidins. In ginkgo leaf they are a minor condensed-flavanol fraction contributing to antioxidant capacity but not to the extract’s characteristic pharmacology.

The building blocks are the ordinary flavan-3-ols — catechin, epicatechin and their gallocatechin relatives — and the dimers procyanidin B1 and procyanidin B2 are the standard reference structures.

Discovery & Commercial Production

The condensed tannins were distinguished from the hydrolysable tannins in the nineteenth century by exactly the reaction that named them: heated with acid, they condense into coloured anthocyanidins rather than hydrolysing into sugars and simple phenolic acids.

Their modern commercial history begins in 1947, when Jack Masquelier isolated the oligomeric flavan-3-ol fraction and developed it, first from pine bark and later from grape seed, into a standardised botanical preparation — the origin of the “OPC” supplement category. That preparation’s analysis has tracked the improvement of the methods available, moving from unspecific colorimetric assays to liquid chromatography–mass spectrometry and nuclear magnetic resonance fingerprinting ^{4Reference 4Weseler AR · 2017ReviewMasquelier’s grape seed extract: from basic flavonoid research to a well-characterized food supplement with health benefits — reviewView study →}.

Production remains extraction rather than synthesis. Grape seed and pine bark are the main feedstocks, and the commercial variables — grape variety, extraction solvent, degree of polymerisation, and which assay defines the label figure — are exactly the ones that make products non-equivalent ^{4Reference 4Weseler AR · 2017ReviewMasquelier’s grape seed extract: from basic flavonoid research to a well-characterized food supplement with health benefits — reviewView study →}.

Toxicity & Safety

Proanthocyanidins carry a low flag. They are ordinary dietary polyphenols eaten daily in fruit, cocoa, tea and wine, and the standardised extracts have a good tolerability record in trials ^{2,5Reference 2Williams G et al. · 2023Systematic reviewCranberries for preventing urinary tract infections — systematic reviewView study →Reference 5Odai T et al. · 2019RCTEffects of grape seed proanthocyanidin extract on vascular endothelial function in participants with prehypertension: a randomized, double-blind, placebo-controlled study — randomised controlled trialView study →}.

The characteristic issue is the one that follows from being a tannin: they bind proteins and minerals in the gut. High intakes can modestly reduce the absorption of dietary non-haem iron and of protein, which matters mainly for people with marginal iron status, and taking tannin-rich preparations away from iron-containing meals is the usual practical answer. Concentrated tannin preparations can also irritate the stomach on an empty stomach, the same property that makes strong astringent teas unpleasant.

On interactions, the picture is milder than often implied. Testing nine brands of grape seed extract against human CYP3A4 in vitro, four had no effect and five produced mild-to-moderate inhibition ranging from 6.4% to 26.8% — while green tea extract, tested alongside, ranged from 5.6% to 89.9% inhibition depending on brand ^{7Reference 7Wanwimolruk S et al. · 2009In vitroVariable inhibitory effect of different brands of commercial herbal supplements on human cytochrome P-450 CYP3A4 — in vitroView study →}. So the notable finding in that study is brand-to-brand variability, and the pronounced inhibitor was green tea rather than grape seed. Grape seed extracts have a theoretical antiplatelet consideration on their vascular pharmacology, though the trials report good tolerability ^{4,5Reference 4Weseler AR · 2017ReviewMasquelier’s grape seed extract: from basic flavonoid research to a well-characterized food supplement with health benefits — reviewView study →Reference 5Odai T et al. · 2019RCTEffects of grape seed proanthocyanidin extract on vascular endothelial function in participants with prehypertension: a randomized, double-blind, placebo-controlled study — randomised controlled trialView study →}.

Cranberry preparations are well tolerated in the Cochrane trials, with adherence rather than adverse effects being the usual limitation ^{2Reference 2Williams G et al. · 2023Systematic reviewCranberries for preventing urinary tract infections — systematic reviewView study →}. Pregnancy and lactation decisions belong on the herb or product page; the cranberry review found no benefit in pregnancy but did not identify harm ^{2Reference 2Williams G et al. · 2023Systematic reviewCranberries for preventing urinary tract infections — systematic reviewView study →}.

Safety at a Glance

✅ Low / no toxicity

• Ordinary dietary polyphenols. Eaten daily in fruit, cocoa and tea, with good tolerability in trials of standardised extracts.
• Poorly absorbed, which limits systemic exposure — a constraint on the claims more than a safety concern.
• They are tannins. High intakes bind dietary protein and non-haem iron; separate tannin-rich preparations from iron-containing meals if iron status is marginal.
• Products are not equivalent. Oligomer size and proanthocyanidin content vary between manufacturers, and different brands gave different results in the same CYP3A4 assay.
• A-type and B-type are not interchangeable. A grape or apple proanthocyanidin does not substitute for cranberry’s anti-adhesion activity.

Dosage

There is no dose for a class. The figures below are the preparations and doses used in research. These are doses studied in research and are not a personal recommendation.

References

1. Howell AB, Reed JD, Krueger CG, et al. (2005). A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity — in vitro and clinical trial. Phytochemistry. https://pubmed.ncbi.nlm.nih.gov/16055161/
2. Williams G, Stothart CI, Hahn D, et al. (2023). Cranberries for preventing urinary tract infections — systematic review. Cochrane Database Syst Rev. https://pubmed.ncbi.nlm.nih.gov/37947276/
3. Howell AB, Botto H, Combescure C, et al. (2010). Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study — randomised controlled trial. BMC Infect Dis. https://pubmed.ncbi.nlm.nih.gov/20398248/
4. Weseler AR, Bast A (2017). Masquelier’s grape seed extract: from basic flavonoid research to a well-characterized food supplement with health benefits — review. Nutr J. https://pubmed.ncbi.nlm.nih.gov/28103873/
5. Odai T, Terauchi M, Kato K, et al. (2019). Effects of grape seed proanthocyanidin extract on vascular endothelial function in participants with prehypertension: a randomized, double-blind, placebo-controlled study — randomised controlled trial. Nutrients. https://pubmed.ncbi.nlm.nih.gov/31757033/
6. Hollands WJ, Philo M, Perez-Moral N, et al. (2020). Monomeric flavanols are more efficient substrates for gut microbiota conversion to hydroxyphenyl-γ-valerolactone metabolites than oligomeric procyanidins: a randomized, placebo-controlled human intervention trial — randomised controlled trial. Mol Nutr Food Res. https://pubmed.ncbi.nlm.nih.gov/32223044/
7. Wanwimolruk S, Wong K, Wanwimolruk P (2009). Variable inhibitory effect of different brands of commercial herbal supplements on human cytochrome P-450 CYP3A4 — in vitro. Drug Metabol Drug Interact. https://pubmed.ncbi.nlm.nih.gov/19353999/
8. Huang S, Yang N, Liu Y, et al. (2012). Grape seed proanthocyanidins inhibit colon cancer-induced angiogenesis through suppressing the expression of VEGF and Ang1 — in vitro. Int J Mol Med. https://pubmed.ncbi.nlm.nih.gov/23026853/
9. Bagchi D, Swaroop A, Preuss HG, et al. (2014). Free radical scavenging, antioxidant and cancer chemoprevention by grape seed proanthocyanidin: an overview — review. Mutat Res. https://pubmed.ncbi.nlm.nih.gov/24751946/
10. Piberger H, Oehme A, Hofmann C, et al. (2011). Bilberries and their anthocyanins ameliorate experimental colitis — animal in vivo. Mol Nutr Food Res. https://pubmed.ncbi.nlm.nih.gov/21957076/
11. Pietarinen SP, Willför SM, Ahotupa MO, Hemming JE, Holmbom BR (2006). Knotwood and bark extracts: strong antioxidants from waste materials. Journal of Wood Science. https://doi.org/10.1007/s10086-005-0780-1
12. European Medicines Agency, Committee on Herbal Medicinal Products (2015). Assessment report on Vaccinium myrtillus L., fructus recens and fructus siccus — monograph. EMA/HMPC/375808/2014.

View all 12 references▾